Work

Permissive Cardiotoxicity: When the Optimal Is the Enemy of the Good

Year: 2025

Type: article

Abstract: Cancer and cardiovascular diseases are the leading causes of mortality worldwide.As these diseases share common metabolic pathways, patients with cancer are currently seen as having subclinical alterations with great potential for developing cardiovascular diseases (and vice versa).This tenuous interrelationship has led to the emergence of cardiooncology (CO) as an area of study and discussion, with a major impact on the management of these cases.In clinical practice, CO is dominated by the dilemma of how to best manage cardiovascular toxicity during cancer Central Illustration: Permissive Cardiotoxicity: When the Optimal Is the Enemy of the Good Imagem Cardiovascular ABC

Source: ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR

DOI: 10.36660/abcimg.20240115i

Authors: Carolina Maria Pinto Domingues Carvalho Silva, Juliane Dantas Seabra-Garcez, Ana Palmira Lima Neves, Ariane Vieira Scarlatelli Macedo

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4409089492

FWCI: 0.633

Cites: 24

Cited by: 1

Related to: 10